东非O型口蹄疫病毒的遗传与抗原特征分析以筛选合适疫苗株
对1993至2012年东非和北非分离的80株O型口蹄疫病毒进行衣壳测序和牛抗血清病毒中和试验,评估3株现有疫苗株和3株候选疫苗株的交叉反应。结果显示疫苗株与多数野外分离株血清学交叉反应良好,O/PanAsia-2和O/Manisa对东非O型病毒保护范围更广。
要点
- O/KEN/77/78对主要流行拓扑型EA-2和EA-3的体外匹配度较低。
- O/PanAsia-2和O/Manisa对东非O型病毒显示更广的保护。
- 疫苗选择不应成为疫苗接种控制O型口蹄疫的主要制约。
核心结论
- 疫苗株与多数野外分离株血清学交叉反应良好,疫苗选择不应成为疫苗接种控制O型口蹄疫的主要制约,本地和国际商业疫苗均可使用。
- O/KEN/77/78对主要流行拓扑型EA-2和EA-3的体外匹配度较低,而O/PanAsia-2和O/Manisa对东非O型病毒保护范围更广。
研究设计与样本
- 对1993至2012年从东非和北非分离的80株O型口蹄疫病毒进行衣壳测序和牛抗血清病毒中和试验。
- 使用3株现有疫苗株(O/KEN/77/78、O/Manisa、O/PanAsia-2)和3株候选疫苗株(O/EA/2002、O/EA/2009、O/EA/2010)的牛抗血清进行中和试验。
主要发现
- 病毒遗传上分为东非起源(进一步分为EA-1、EA-2、EA-3和EA-4四个拓扑型)和中东-南亚(ME-SA)拓扑型。
- ME-SA拓扑型病毒主要在埃及和利比亚检测到,反映与中东国家的贸易联系。
- 疫苗株与多数野外分离株血清学交叉反应良好。
- O/KEN/77/78对主要流行拓扑型EA-2和EA-3的体外匹配度较低,而O/PanAsia-2和O/Manisa对东非O型病毒保护范围更广,尽管遗传上属于ME-SA拓扑型。
临床怎么用
- 疫苗选择不应成为疫苗接种控制O型口蹄疫的主要制约,本地和国际商业疫苗均可使用。
- O/PanAsia-2和O/Manisa对东非O型病毒保护范围更广,尽管遗传上属于ME-SA拓扑型。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Foot-and-mouth disease (FMD) is endemic in Eastern Africa with circulation of multiple serotypes of the virus in the region. Most of the outbreaks are caused by serotype O followed by serotype A. The lack of concerted FMD control programmes in Africa has provided little incentive for vaccine producers to select vaccines that are tailored to circulating regional isolates creating further negative feedback to deter the introduction of vaccine-based control schemes. In this study a total of 80 serotype O FMD viruses (FMDV) isolated from 1993 to 2012 from East and North Africa were characterized by virus neutralisation tests using bovine antisera to three existing (O/KEN/77/78, O/Manisa and O/PanAsia-2) and three putative (O/EA/2002, O/EA/2009 and O/EA/2010) vaccine strains and by capsid sequencing. Genetically, these viruses were grouped as either of East African origin with subdivision into four topotypes (EA-1, 2, 3 and 4) or of Middle-East South Asian (ME-SA) topotype. The ME-SA topotype viruses were mainly detected in Egypt and Libya reflecting the trade links with the Middle East countries. There was good serological cross-reactivity between the vaccine strains and most of the field isolates analysed, indicating that vaccine selection should not be a major constraint for control of serotype O FMD by vaccination, and that both local and internationally available commercial vaccines could be used. The O/KEN/77/78 vaccine, commonly used in the region, exhibited comparatively lower percent in vitro match against the predominant topotypes (EA-2 and EA-3) circulating in the region whereas O/PanAsia-2 and O/Manisa vaccines revealed broader protection against East African serotype O viruses, even though they genetically belong to the ME-SA topotype.
引用
- Lloyd-Jones K, Mahapatra M, Upadhyaya S, et al. Genetic and antigenic characterization of serotype O FMD viruses from East Africa for the selection of suitable vaccine strain. Vaccine. 2017. PMID: 29102329. doi:10.1016/j.vaccine.2017.10.040
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。